Eva De Mol Selected Research

EPI 001

1/2016

EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva De Mol Research Topics

Disease

3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2016
1	Disease Progression 01/2016

Drug/Important Bio-Agent (IBA)

3	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2018
1	BuffersIBA 01/2021
1	SolventsIBA 01/2021
1	AndrogensIBA 01/2016
1	SolutionsIBA 01/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2016
1	EPI 001IBA 01/2016

Therapy/Procedure

3	Castration 01/2021 - 01/2016
1	Therapeutics 01/2016